Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder

Brain, Behavior, and Immunity

Volumn 40, Issue , 2014, Pages 235-243

  Kéri, Szabolcs ^a,b,c   Szabó, Csilla ^b   Kelemen, Oguz ^d  

^a BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Cognitive behavioral therapy; Inflammation; Major depressive disorder; Toll Like Receptors

Indexed keywords

C REACTIVE PROTEIN; DNA 16S; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; RNA 16S; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; MESSENGER RNA;

ADULT; ARTICLE; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; MAJOR DEPRESSION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; YOUNG ADULT; BLOOD; DEPRESSIVE DISORDER, MAJOR; METABOLISM; MONONUCLEAR CELL;

ADULT; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; NF-KAPPA B; RNA, MESSENGER; RNA, RIBOSOMAL, 16S; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84904131824     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.03.020     Document Type: Article

References (96)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 2000, 157(4 Suppl):1-45.
3. Anderson G., Berk M., Maes M. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatr. Scand. 2014, 129:83-97.
4. Antoni M.H., Lutgendorf S.K., Blomberg B., Carver C.S., Lechner S., Diaz A., Stagl J., Arevalo J.M., Cole S.W. Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics. Biol. Psychiatry 2012, 71:366-372.
5. Baine M.J., Mallya K., Batra S.K. Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients. Methods Mol. Biol. 2013, 980:157-173.
6. Barger S.W., Moerman A.M., Mao X. Molecular mechanisms of cytokine-induced neuroprotection: NFkappaB and neuroplasticity. Curr. Pharm. Des. 2005, 11:985-998.
7. Beck A.T. Cognitive Therapy and the Emotional Disorders 1976, International Universities Press, New York, NY.
8. Berk M., Williams L.J., Jacka F.N., O'Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., Maes M. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 2013, 11:200.
9. Bhasin M.K., Dusek J.A., Chang B.H., Joseph M.G., Denninger J.W., Fricchione G.L., Benson H., Libermann T.A. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One 2013, 8:e62817.
10. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. USA 2003, 100:1920-1925.
11. Cacioppo J.T., Hawkley L.C., Berntson G.G. The anatomy of loneliness. Curr. Dir. Psychol. Sci. 2003, 12:71-74.
12. Caso J.R., Pradillo J.M., Hurtado O., Leza J.C., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 2008, 39:1314-1320.
13. Castrén E. Neuronal network plasticity and recovery from depression. JAMA Psychiatry 2013, 70:983-989.
14. Chamorro S., Garcia-Vallejo J.J., Unger W.W., Fernandes R.J., Bruijns S.C., Laban S., Roep B.O., Hart B.A., van Kooyk Y. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 2009, 183:2984-2994.
15. Chen E., Miller G.E. Socioeconomic status and health: mediating and moderating factors. Annu. Rev. Clin. Psychol. 2013, 9:723-749.
16. Chen H.Y., Cheng I.C., Pan Y.J., Chiu Y.L., Hsu S.P., Pai M.F., Yang J.Y., Peng Y.S., Tsai T.J., Wu K.D. Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. Kidney Int. 2011, 80:415-422.
17. Collins S.M. Stress and the gastrointestinal tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G315-G318.
18. Currier M.B., Nemeroff C.B. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu. Rev. Med. 2014, 65:203-221.
19. Dickerson S.S., Gable S.L., Irwin M.R., Aziz N., Kemeny M.E. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Psychol. Sci. 2009, 20:1237-1244.
20. Doering L.V., Cross R., Vredevoe D., Martinez-Maza O., Cowan M.J. Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Altern. Ther. Health. Med. 2007, 13:18-21.
21. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
22. Fang H., Wang P.F., Zhou Y., Wang Y.C., Yang Q.W. Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J. Neuroinflamm. 2013, 10:27.
23. Frodl T., Amico F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:295-303.
24. Eisenberger N.I., Inagaki T.K., Mashal N.M., Irwin M.R. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 2010, 24:558-563.
25. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 1995, 95:1669-1675.
26. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press, Washington, DC.
27. Fuligni A.J., Telzer E.H., Bower J., Irwin M.R., Kiang L., Cole S.W. Daily family assistance and inflammation among adolescents from Latin American and European backgrounds. Brain Behav. Immun. 2009, 23:803-809.
28. Gárate I., García-Bueno B., Madrigal J.L., Bravo L., Berrocoso E., Caso J.R., Micó J.A., Leza J.C. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J. Neuroinflamm. 2011, 8:151.
29. Gárate I., Garcia-Bueno B., Madrigal J.L., Caso J.R., Alou L., Gomez-Lus M.L., Micó J.A., Leza J.C. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol. Psychiatry 2013, 73:32-43.
30. García-Álvarez M., Berenguer J., Guzman-Fulgencio M., Alvarez E., Cosín J., Micheloud D., Jimenez-Sousa M.A., Fernández-Rodríguez A., Aldámiz-Echevarría T., Carrero A., Miralles P., Resino S. Bacterial DNA translocation and liver disease severity among HIV-infected patients with chronic hepatitis C. J. Acquir. Immune Defic. Syndr. 2012, 61:552-556.
31. Glei D.A., Goldman N., Lin Y.H., Weinstein M. Relaxation practice and physiologic regulation in a national sample of older Taiwanese. J. Altern. Complement. Med. 2012, 18:653-661.
32. Hackett R.A., Hamer M., Endrighi R., Brydon L., Steptoe A. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology 2012, 37:1801-1809.
33. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
34. Hänsel A., Hong S., Cámara R.J., von Känel R. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci. Biobehav. Rev. 2010, 35:115-121.
35. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychol. Bull. 1993, 113:472-486.
36. Hermida A.P., McDonald W.M., Steenland K., Levey A. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?. Expert Rev. Neurother. 2012, 12:1339-1350.
37. Hiles S.A., Baker A.L., de Malmanche T., Attia J. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol. Med. 2012, 42:2015-2026.
38. Hoesel B., Schmid J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 2013, 12:86.
39. Hollingshead, A.B. 1975. Four Factor Index of Social Status. Unpublished working paper, Department of Sociology, Yale University.
40. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
41. Huffman J.C., Celano C.M., Beach S.R., Motiwala S.R., Januzzi J.L. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc. Psychiatry Neurol. 2013, 2013:695925.
42. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
43. Jaremka L.M., Fagundes C.P., Peng J., Bennett J.M., Glaser R., Malarkey W.B., Kiecolt-Glaser J.K. Loneliness promotes inflammation during acute stress. Psychol. Sci. 2013, 24:1089-1097.
44. Jiang W., Lederman M.M., Hunt P., Sieg S.F., Haley K., Rodriguez B., Landay A., Martin J., Sinclair E., Asher A.I., Deeks S.G., Douek D.C., Brenchley J.M. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 2009, 199:1177-1185.
45. Kane T.D., Alexander J.W., Johannigman J.A. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann. Surg. 1998, 227:1-9.
46. Kiecolt-Glaser J.K., Loving T.J., Stowell J.R., Malarkey W.B., Lemeshow S., Dickinson S.L., Glaser R. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch. Gen. Psychiatry 2005, 62:1377-1384.
47. Kiecolt-Glaser J.K., Christian L., Preston H., Houts C.R., Malarkey W.B., Emery C.F., Glaser R. Stress, inflammation, and yoga practice. Psychosom. Med. 2010, 72:113-121.
48. Koedel U., Merbt U.M., Schmidt C., Angele B., Popp B., Wagner H., Pfister H.W., Kirschning C.J. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am. J. Pathol. 2007, 171:200-213.
49. Kokkinopoulos I., Jordan W.J., Ritter M.A. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol. Immunol. 2005, 42:957-968.
50. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA 2010, 107:2669-2674.
51. Kovács Z.A., Puskás L.G., Juhász A., Rimanóczy A., Hackler L., Kátay L., Gali Z., Vetró A., Janka Z., Kálmán J. Hypnosis upregulates the expression of immune-related genes in lymphocytes. Psychother. Psychosom. 2008, 77:257-259.
52. Kronfol Z., Silva J., Greden J., Dembinski S., Gardner R., Carroll B. Impaired lymphocyte function in depressive illness. Life Sci. 1983, 33:241-247.
53. Leulier F., Lemaitre B. Toll-like receptors-taking an evolutionary approach. Nat. Rev. Genet. 2008, 9:165-178.
54. Lucas K., Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 2013, 48:190-204.
55. Kuo H.K., Yen C.J., Chang C.H., Kuo C.K., Chen J.H., Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005, 4:371-380.
56. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 1999, 4:317-327.
57. Liu X., Wang C., Ye Z., Kijlstra A., Yang P. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease. Invest. Ophthalmol. Vis. Sci. 2013, 54:6012-6017.
58. Lopresti A.L., Hood S.D., Drummond P.D. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J. Affect. Disord. 2013, 148:12-27.
59. Lutgendorf S., Logan H., Kirchner H.L., Rothrock N., Svengalis S., Iverson K., Lubaroff D. Effects of relaxation and stress on the capsaicin-induced local inflammatory response. Psychosom. Med. 2000, 62:524-534.
60. Maes M., Coucke F., Leunis J.C. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro. Endocrinol. Lett. 2007, 28:739-744.
61. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro. Endocrinol. Lett. 2008, 29:117-124.
62. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:664-675.
63. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, 141:55-62.
64. Maes M., Kubera M., Leunis J.C., Berk M., Geffard M., Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 2013, 127:344-354.
65. Malarkey W.B., Jarjoura D., Klatt M. Workplace based mindfulness practice and inflammation: a randomized trial. Brain Behav. Immun. 2013, 27:145-154.
66. Mawdsley J.E., Jenkins D.G., Macey M.G., Langmead L., Rampton D.S. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am. J. Gastroenterol. 2008, 103:1460-1469.
67. McCusker R.H., Kelley K.W. Immune-neural connections: how the immune system's response to infectious agents influences behavior. J. Exp. Biol. 2013, 216:84-98.
68. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
69. Miller G.E., Rohleder N., Cole S.W. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom. Med. 2009, 71:57-62.
70. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. J. Neurosci. 2011, 31:9075-9083.
71. Morris G., Maes M. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med. 2013, 11:205.
72. Murphy M.L., Slavich G.M., Rohleder N., Miller G.E. Targeted rejection triggers differential pro- and anti-inflammatory in adolescents as a function of psychosocial status. Clin. Psychol. Sci. 2013, 1:30-40.
73. Na K.S., Lee K.J., Lee J.S., Cho Y.S., Jung H.Y. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:79-85.
74. Nazari M., Khodadadi H., Fathalizadeh J., Hassanshahi G., Bidaki R., Ayoobi F., Hajebrahimi B., Bagheri F., Arababadi M.K. Defective NF-κB transcription factor as the mediator of inflammatory responses: a study on depressed Iranian medical students. Clin. Lab. 2013, 59:827-830.
75. Odenwald M.A., Turner J.R. Intestinal permeability defects: is it time to treat?. Clin. Gastroenterol. Hepatol. 2013, 11:1075-1083.
76. Ohashi K., Burkart V., Flohé S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 2000, 164:558-561.
77. Pace T.W., Wingenfeld K., Schmidt I., Meinlschmidt G., Hellhammer D.H., Heim C.M. Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder. Brain Behav. Immun. 2012, 26:13-17.
78. Perczel Forintos D., Mórocz K. Kognitív viselkedésterápia 2010, Medicina, Budapest.
79. Ponferrada A., Caso J.R., Alou L., Colon A., Sevillano D., Moro M.A., Lizasoain I., Menchén P., Gómez-Lus M.L., Lorenzo P., Cos E., Leza J.C., Menchén L. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology 2007, 132:1791-1803.
80. Powell N.D., Sloan E.K., Bailey M.T., Arevalo J.M., Miller G.E., Chen E., Kobor M.S., Reader B.F., Sheridan J.F., Cole S.W. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc. Natl. Acad. Sci. USA 2013, 110:16574-16579.
81. Raedler T.J. Inflammatory mechanisms in major depressive disorder. Curr. Opin. Psychiatry 2011, 24:519-525.
82. Rohleder N., Marin T.J., Ma R., Miller G.E. Biologic cost of caring for a cancer patient: Dysregulation of pro- and anti-inflammatory signaling pathways. J. Clin. Oncol. 2009, 27:2909-2915.
83. Rosenkranz M.A., Davidson R.J., Maccoon D.G., Sheridan J.F., Kalin N.H., Lutz A.A. Comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav. Immun. 2013, 27:174-184.
84. Schleifer S.J., Keller S.E., Meyerson A.T., Raskin M.J., Davis K.L., Stein M. Lymphocyte function in major depressive disorder. Arch. Gen. Psychiatry 1984, 41:484-486.
85. Slavich G.M., Way B.M., Eisenberger N.I., Taylor S.E. Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc. Natl. Acad. Sci. USA 2010, 107:14817-14822.
86. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 2001, 167:2887-2894.
87. Soderholm J.D., Perdue M.H. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G7-G13.
88. Swidsinski A., Loening-Baucke V., Theissig F., Engelhardt H., Bengmark S., Koch S., Lochs H., Dörffel Y. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007, 56:343-350.
89. Taube A., Schlich R., Sell H., Eckardt K., Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H2148-H2165.
90. Thornton L.M., Andersen B.L., Schuler T.A., Carson W.E. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom. Med. 2009, 71:715-724.
91. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., Yang H., Li J., Tracey K.J., Geller D.A., Billiar T.R. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 2005, 201:1135-1143.
92. Twisk F.N., Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro. Endocrinol. Lett. 2009, 30:284-299.
93. Verstrepen L., Bekaert T., Chau T.L., Tavernier J., Chariot A., Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol. Life Sci. 2008, 65:2964-2978.
94. Warner-Schmidt J.L., Vanover K.E., Chen E.Y., Marshall J.J., Greengard P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA 2011, 108:9262-9267.
95. White P.D., Goldsmith K.A., Johnson A.L., Potts L., Walwyn R., DeCesare J.C., Baber H.L., Burgess M., Clark L.V., Cox D.L., Bavinton J., Angus B.J., Murphy G., Murphy M., O'Dowd H., Wilks D., McCrone P., Chalder T., Sharpe M. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomized trial. Lancet 2011, 377:823-836. PACE trial management group.
96. Yadav R.K., Magan D., Mehta N., Sharma R., Mahapatra S.C. Efficacy of a short-term yoga-based lifestyle intervention in reducing stress and inflammation: preliminary results. J. Altern. Complement. Med. 2012, 18:662-667.